Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NOAC laboratory monitoring study for dabigatran and rivaroxaban
NL-OMON39575Not yet recruiting
- Sponsor
- Catharina Ziekenhuis
- Start
- Nov 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of dabigatran and rivaroxaban in thrombosis (2 cohorts), sponsored by Catharina Ziekenhuis. Primary endpoint: Comparison of clotting tests with each other and with the gold standard. Planned start Nov 2012; status: not yet recruiting.
02
Drugs
dabigatranrivaroxaban
03
Conditions
thrombosis
Beyond the preview
Go deeper on NL-OMON39575.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON39575.